Education
About Us
Working with TipRanks
Follow Us
Nano-X Imaging (NNOX)
NASDAQ:NNOX
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.23Last Year’s EPS
-0.21Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 31, 2025
|% Change Since: -15.87%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a mix of achievements and challenges. Regulatory milestones and market expansion in Europe are notable highlights. However, the increased net loss, ongoing gross losses in certain segments, and stagnation in AI solutions revenue temper the positive developments.Company Guidance
During the Nano-X Fourth Quarter 2024 Earnings Call, the company provided several key metrics and updates. Nano-X reported a GAAP net loss of $14.1 million for the fourth quarter of 2024, up from a $10.2 million net loss in the same period the previous year. Revenue for the quarter was $3.0 million, with a GAAP gross loss of $2.9 million. The teleradiology services segment generated $2.8 million in revenue, contributing to a gross profit of $0.6 million on a GAAP basis. The company also noted an increase in its total AI customer and pilot-based projects by 25%. In terms of market expansion, Nano-X achieved FDA clearance and CE-mark designation for its Nanox.ARC system, which includes plans for deployment in the U.S. and entry into the European market. Additionally, Nano-X highlighted its efforts in strategic partnerships and sales agreements to accelerate its market presence, particularly in the U.S., where it is focusing on expanding its sales and clinical support teams.Regulatory Achievements
Nano-X achieved significant regulatory milestones, including FDA general use clearance in December 2024 and CE mark designation for the Nanox.ARC in February 2025.
Market Expansion
The company is expanding its market presence by entering the European market with CE-marked Nanox.ARC and signing new distribution agreements in Romania and Greece.
AI Commercialization Advances
Nano-X engaged with two new customers in the U.S. for its AI-powered imaging interpretation algorithms and increased its AI customer and pilot-based project by 25%.
Financial Performance in Teleradiology
Teleradiology services revenue increased to $2.8 million with a gross profit margin of 21% on a GAAP basis, up from 14% in the previous year.
---
NNOX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NNOX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 31, 2025 | $5.23 | $5.00 | -4.40% |
| Nov 21, 2024 | $5.89 | $6.16 | +4.58% |
| Aug 20, 2024 | $7.24 | $7.13 | -1.52% |
| May 28, 2024 | $8.43 | $8.49 | +0.71% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Nano-X Imaging (NNOX) report earnings?
Nano-X Imaging (NNOX) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Nano-X Imaging (NNOX) earnings time?
Nano-X Imaging (NNOX) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NNOX EPS forecast?
NNOX EPS forecast for the fiscal quarter 2025 (Q1) is -0.23.
---
